The following is from Reuters. Pfizer (PFE.N) on Tuesday [August 1] said it will launch a cost-cutting program if its Covid-19 vaccine and antiviral treatment keep underperforming expectations in the coming months due to plunging demand. Pfizer said it anticipates more clarity […]
Pfizer might need to cut costs, as demand for Covid products falls Read More »
The following is an excerpt from CNBC. Moderna on Wednesday said it struck a deal with Chinese officials to research, develop and manufacture messenger RNA medicines in the country, despite rising tensions between the U.S. and China. The Massachusetts-based biotech company signed a memorandum
Moderna set to manufacture mRNA drugs for people of China Read More »
The following is an excerpt from The Vaccine Reaction. A recently disclosed contract reveals that the U.S. government received millions of dollars in licensing fees from Moderna, Inc. The company paid the National Institutes of Health (NIH) $400 million to
U.S. govt. pockets $400 million from Moderna Covid-19 vaccines Read More »
The following is an excerpt from The Vaccine Reaction. Pharmaceutical companies GSK (formerly known as GlaxoSmithKline), Moderna and CSL Seqirus announced that they are developing and ready to test human vaccines against avian influenza H5N1 (also known as bird flu)
Pharma developing human bird flu vaccine for possible future pandemic Read More »
The following is an excerpt from Reuters. A tangle of high-stakes U.S. patent disputes over Covid-19 vaccines could be tamed by court rulings or grow even more complex next year. In the headlining fight, Moderna sued Pfizer and BioNTech in August, accusing
Covid-19 vaccine patent battles continue into 2023 Read More »
The watchdog group Judicial Watch has received 699 pages of records from the Department of Health and Human Services (HHS) regarding data vaccine maker Moderna submitted to the Food and Drug Administration (FDA) on the company’s mRNA Covid-19 vaccine. The records indicate a
The following is an excerpt from Paul D. Thacker’s latest article in his Substack newsletter: The DisInformation Chronicle. “Weber Shandwick Provides PR for Moderna and Pfizer, While Staffing the CDC’s Vaccine Office.” In an odd case of synchronicity—and let’s be
(READ) Moderna and Pfizer PR firm housed in CDC vaccine offices Read More »
The following is an excerpt from Becker’s Hospital Review. Moderna and Merck entered an agreement Oct. 12 to develop, manufacture and sell personalized cancer vaccine candidates. The two drugmakers have been collaborators since 2016, but under the amended agreement, Merck will pay
Moderna, Merck join forces to develop cancer vaccine Read More »
